Boston Scientific Recalls HOT AXIOS Stent and Delivery System Due to Deployment Failures
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific Corporation is recalling 588 units of the HOT AXIOS Stent and Delivery System due to reports of deployment and expansion issues that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Boston Scientific Corporation has initiated a voluntary recall of the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall was triggered by an increase in reports regarding stent deployment and expansion issues. According to the firm, these malfunctions can lead to procedural complications that may necessitate additional medical interventions.
Which Products Are Affected
The recall affects the following medical device:
- Product Name: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System (20mm x 10mm)
- Material Number (UPN): M00553560
- UDI-DI: 8714729951100
- Recall Number: Z-1163-2026
- Quantity: 588 units
- Affected Lot Numbers: This recall includes over 200 specific lot numbers, including but not limited to: 35793920, 35952745, 35961004, 35995006, 35995007, 35995165, 36001950, 36001951, 36001952, 36001953, 36002902, and 36002903.
This product was distributed worldwide, including nationwide across the United States and Puerto Rico, as well as in over 50 other countries including Canada, Germany, Japan, and the United Kingdom.
What You Should Do
Healthcare facilities and providers should immediately identify and sequester any affected units in their inventory. Boston Scientific Corporation, located at 100 Boston Scientific Way, Marlborough, MA 01752, initiated this voluntary recall on December 19, 2025. Providers should follow the firm's instructions for the return or exchange of the affected devices.
Why This Matters
Difficulty in deploying or expanding the stent can lead to a prolongation of the medical procedure. In the most serious cases, a failure of the first flange to deploy or expand can result in a cascade of events requiring additional endoscopic or surgical intervention to remove the stent and close the puncture site.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.